Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| EPICEPT CORP | 700,000 | reported | 25 Jan 2017 | tx 4+640,000 |
| AVENUE THERAPEUTICS, INC. | 79,663 | reported | 10 Dec 2018 | tx 3+29,663 |
| Journey Medical Corp | 70,727 | reported | 28 Nov 2023 | tx 8+116,717−4,245 |
| Travere Therapeutics, Inc. | 51,665 | reported | 14 Aug 2014 | tx 2+12,000−20,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Nov 2023 | SALE | Journey Medical Corp | 2,245 | 3.48 USD | |
| 08 Nov 2023 | SALE | Journey Medical Corp | 255 | 3.76 USD | |
| 28 Nov 2023 | SALE | Journey Medical Corp | 1,745 | 5.22 USD | |
| 06 Oct 2023 | PURCHASE | Journey Medical Corp | 15,000 | 2.98 USD | |
| 21 Sept 2023 | PURCHASE | Journey Medical Corp | 30,000 | 2.97 USD | first after silence |
| 21 Jul 2023 | GRANT_AWARD | Journey Medical Corp | 27,472 | 0.00 USD | |
| 21 Jul 2022 | GRANT_AWARD | Journey Medical Corp | 14,245 | 0.00 USD | |
| 14 Jan 2022 | GRANT_AWARD | Journey Medical Corp | 30,000 | 0.00 USD | |
| 10 Dec 2018 | PURCHASE | AVENUE THERAPEUTICS, INC. | 5,000 | 4.76 USD | |
| 03 Dec 2018 | PURCHASE | AVENUE THERAPEUTICS, INC. | 10,000 | 5.48 USD | |
| 07 Aug 2018 | GIFT | AVENUE THERAPEUTICS, INC. | 14,663 | 0.00 USD | |
| 25 Jan 2017 | GRANT_AWARD | EPICEPT CORP | 500,000 | 0.00 USD | deriv |
| 01 Jun 2016 | GRANT_AWARD | EPICEPT CORP | 50,000 | 0.00 USD | deriv |
| 23 Feb 2016 | GRANT_AWARD | EPICEPT CORP | 40,000 | 0.00 USD | deriv |
| 23 Feb 2016 | GRANT_AWARD | EPICEPT CORP | 50,000 | 0.00 USD | deriv |
| 14 Aug 2014 | SALE | Travere Therapeutics, Inc. | 20,000 | 12.28 USD | |
| 06 Dec 2013 | GRANT_AWARD | Travere Therapeutics, Inc. | 12,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 21 Sept 2023.